CVX — Carvolix SA Share News
0.000.00%
- €369.63m
- €382.09m
Brief: Affluent Medical Announces Successful First-In-Human Implantation Of Its Artificial Sphincter Artus For The Treatment Of Stress Urinary Incontinence
Brief: Affluent Medical Closes Bridge Of 3.5 Million Euros Via Capital Increase From Key Shareholders
Brief: Affluent Medical H1 Operating Loss EUR 7.4 Mln
Brief: Affluent Medical Announces Positive Clinical 1-Yr Results For Kalios
Brief: Affluent Medical Appoints Christophe De Vregille As CFO
Brief: Affluent Medical: Positive Results One Month After Mitral Heart Valve Implantation In First Patient
Brief: Affluent Medical Net Loss Widens To EUR 15.2 Mln
Brief: Affluent Medical: Initial Success Of First Clinical Implantation Of Epygon Mitral Heart Valve Via Minimally Invasive Route
Brief: Affluent Medical Launches Capital Increase Of About EUR 13 Million
Brief: Affluent Medical Appoints Michel Therin As Chairman
Brief: Affluent Medical Says 24 Patients Implanted With Kalios
Brief: Affluent Medical End-June Net Loss Widens To EUR 8.2 Mln
Brief: Affluent Medical Raises EUR 6 Mln
Brief: Affluent Medical Launches Capital Increase With Preferential Subscription Rights
Brief: Affluent Medical: Excellent Security, Efficacy Results In Optimize II Study
Brief: Affluent Medical FY Net Loss Widens To EUR 14.8 Million
Brief: Affluent Medical H1 Current Operating Loss Widens To 7.4 Million Euros
Brief: Affluent Medical: Success Of First Adjustment Of Kalios Mitral Ring